Outcomes made possible by Full MagLev Flow Technology

Why the HeartMate 3 LVAD

Time may run out for patients put on the waiting list, to receive a heart transplantation. Their condition may require earlier intervention than a donor heart would become available. Some of these patients may benefit from a left ventricular assist device (LVAD), an implanted heart pump which can help the heart pump oxygen-rich blood throughout the body and potentially improve the symptoms of advanced heart failure.¹

An LVAD is designed to restore blood flow and improve survival outcome, functional status, and quality of life in patients while minimizing complications such as stroke and thrombosis. Intended for a broad range of advanced heart failure patients, LVADs are an option for patients with NYHA Class IIIB or IV heart failure and can be used for both short-term and long-term heart support including:

• Bridge to transplantation: short term (ST) indication (for people waiting for a donor heart)
• Destination therapy: long term (LT) indication also called permanent support (for people who are ineligible for heart transplantation)

Advanced Heart Failure Treatment for Better Quality of Life

You may find it reassuring to know that there are thousands of people around the world with LVADs living active, productive lives. They are spending time with friends and family and doing the things they love.⁵

HeartMate 3 LVADs set the standard in heart failure LVAD therapy through innovation, experience and outstanding outcomes.¹ Our goal, like yours, is to keep patients with heart failure moving forward with the best possible quality of life.

References

1. Mehra M, Uriel N, Naka Y, et al. A Fully Magnetically Levitated Left Ventricular Assist Device-Final Report. N Engl J Med. 2019;380:1618-1627.
2. Abbott data on file.
3. Bourque K, Cotter C, Dague C, et al. Design rationale and preclinical evaluation of the HeartMate 3 Left Ventricular Assist System for hemocompatibility. Am Soc Artificial Int Organs. 2016;62:375- 383.
4. Bourque K, Dague C, Farrar D, et al. In vivo assessment of a rotary left ventricular assist device induced artificial pulse in the proximal and distal aorta. Artificial Organs. 2006;30:638-642.
5. Abbott Data on File as of March 2021.